We served as lead counsel to Triple Tree Capital Partners, Noro Moseley Partners and SSM Partners in the formation of its holding company, Riva Health Holdings, Inc., a newly formed holding company that facilitated the merger of Revel and NovuHealth.
Riva Health Holdings, Inc., combined through Triple Tree Capital Partners portfolio company – Revel – and Noro Moseley Partners and SSM Partners portfolio company – NovuHealth – forms the largest technology platform company focused on healthcare member engagement. Working with more than 50 healthcare organizations, including seven of the top 10 largest health insurers in the United States representing more than 65 percent of all members in government programs such as Medicare and Medicaid, Revel and NovuHealth serve some of healthcare’s most trusted organizations.
The deal team was led by Bass, Berry & Sims Private Equity Chair and Healthcare Private Equity Co-Chair Ryan Thomas and included corporate attorneys Ryan Hoffman, Gardner Bell, Whitney Robinson, and David Venturella. Firm attorneys Curtis Fisher and Noah Black advised on employee benefits matters; Nesrin Tift and Olivia Seraphim advised on healthcare regulatory matters; Bryan Metcalf counseled on tax matters; Emily Burrows advised on intellectual property matters; Stefanie Chamberlain advised on credit agreement – and real estate –related matters; and Lucas Smith counseled on antitrust matters.
“We are grateful for the opportunity to represent Riva Health in this transaction, which continues to build upon our firm’s experience in transformative private equity deals in the healthcare technology space,” said Ryan Thomas. Ryan also added, “As the industry continues to face increased regulatory and financial pressure, we look forward to seeing how Riva’s next-generation SaaS platform revolutionizes the healthcare action space and impacts outcomes at scale.” Bass, Berry, and Sims recently published a dealmakers guide, where several discuss the healthcare M&A market and take a deep dive into COVID19-related transactional matter for private equity buyers or platforms to consider. More here.
To read the full press release issued by Triple Tree Capital Partners, click here. The transaction was highlighted in several media outlets, including:
- “Revel and NovuHealth Merge to Create Leading Technology Platform Company Focused on Healthcare Member Engagement,” PR Newswire (October 1, 2020)
- “Revel and NovuHealth announce merger of Twin Cities health tech firms,” Minneapolis/St. Paul Business Journal (October 1, 2020)
- “Revel, NovuHealth Merge to Create Largest Healthcare Member Engagement Platform,” HIT Consultant (October 1, 2020)
Revel Health (a portfolio of Triple Tree Capital Partners) is a healthcare technology company that is reinventing health engagement to make it better through its industry-leading health action platform, Revel Connect. Revel Health helps healthcare organizations connect with members and patients in a personalized way to build better healthcare consumer experiences, drive positive health action, and improve health outcomes.
NovuHealth (a portfolio of Noro Moseley Partners and SSM Partners) is the leading healthcare consumer engagement company, driven to improve consumer health and health plan performance. NovuHealth motivates consumers to complete high-value healthcare activities by leveraging its sophisticated engagement platform, proven loyalty and behavioral science strategies, and deep industry and regulatory expertise.
The Healthcare Private Equity Team at Bass, Berry & Sims offers an unmatched combination of sophistication and value. We are focused on serving and adding value in the middle- and lower-middle market, and are uniquely positioned to provide the cost-effective yet sophisticated transactional solutions the current environment demands. Our results-oriented, business-minded deal attorneys work seamlessly with our nationally ranked healthcare regulatory attorneys to help private equity clients and their portfolio companies achieve their strategic goals. We also represent private equity funds in acquisition financings as borrowers and in mezzanine financing as lenders. Most notably, we pride ourselves as being deal facilitators and real-world risk analyzers. As a result of this experience and depth, the firm continues to be recognized as a staple law firm for private equity funds investing in healthcare. To learn more about our team, industry experience and value-add, click here.